Cannara Biotech Inc. – TSX:LOVE.V
Cannara Biotech stock price today
Cannara Biotech stock price monthly change
Cannara Biotech stock price quarterly change
Cannara Biotech stock price yearly change
Cannara Biotech key metrics
Market Cap | 77.73M |
Enterprise value | 6.97B |
P/E | 3.59 |
EV/Sales | 176.09 |
EV/EBITDA | 730.96 |
Price/Sales | 175.05 |
Price/Book | 102.99 |
PEG ratio | 0.01 |
EPS | 0.03 |
Revenue | 66.88M |
EBITDA | 12.61M |
Income | 3.47M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 7.17% |
Oper. margin | 15.32% |
Gross margin | 49.37% |
EBIT margin | 15.32% |
EBITDA margin | 18.85% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeCannara Biotech stock price history
Cannara Biotech stock forecast
Cannara Biotech financial statements
| Feb 2023 | 13.03M | -641.59K | -4.92% |
|---|---|---|---|
| May 2023 | 15.84M | 2.92M | 18.49% |
| Aug 2023 | 18.33M | 4.63M | 25.27% |
| Feb 2024 | 19.68M | -3.44M | -17.51% |
| Feb 2023 | 129147403 | 57.37M | 44.43% |
|---|---|---|---|
| May 2023 | 135374624 | 60.39M | 44.62% |
| Aug 2023 | 141522254 | 61.77M | 43.65% |
| Feb 2024 | 145824662 | 66.48M | 45.59% |
| Feb 2023 | 376.96K | -1.56M | -1.40M |
|---|---|---|---|
| May 2023 | 2.53M | -2.53M | -107.64K |
| Aug 2023 | 2.83M | -1.61M | -973.29K |
| Feb 2024 | 2.33M | -1.07M | -768.48K |
Cannara Biotech alternative data
| Aug 2023 | 270 |
|---|---|
| Sep 2023 | 270 |
| Oct 2023 | 270 |
| Nov 2023 | 270 |
| Dec 2023 | 270 |
| Jan 2024 | 461 |
| Feb 2024 | 461 |
| Apr 2024 | 461 |
| May 2024 | 461 |
| Jun 2024 | 461 |
| Jul 2024 | 461 |
Cannara Biotech other data
-
What's the price of Cannara Biotech stock today?
One share of Cannara Biotech stock can currently be purchased for approximately $0.12.
-
When is Cannara Biotech's next earnings date?
Unfortunately, Cannara Biotech's (LOVE.V) next earnings date is currently unknown.
-
Does Cannara Biotech pay dividends?
No, Cannara Biotech does not pay dividends.
-
How much money does Cannara Biotech make?
Cannara Biotech has a market capitalization of 77.73M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 42.77% to 81.75M US dollars.
-
What is Cannara Biotech's stock symbol?
Cannara Biotech Inc. is traded on the TSX under the ticker symbol "LOVE.V".
-
What is Cannara Biotech's primary industry?
Company operates in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry.
-
How do i buy shares of Cannara Biotech?
Shares of Cannara Biotech can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
How many employees does Cannara Biotech have?
As Jul 2024, Cannara Biotech employs 461 workers.
-
When Cannara Biotech went public?
Cannara Biotech Inc. is publicly traded company for more then 6 years since IPO on 14 Jan 2019.
-
What is Cannara Biotech's official website?
The official website for Cannara Biotech is cannara.ca.
-
Where are Cannara Biotech's headquarters?
Cannara Biotech is headquartered at 333 Decarie Blvd., Saint-Laurent, QC.
-
How can i contact Cannara Biotech?
Cannara Biotech's mailing address is 333 Decarie Blvd., Saint-Laurent, QC.
Cannara Biotech company profile:
Cannara Biotech Inc.
cannara.caTSX
461
Drug Manufacturers—Specialty & Generic
Healthcare
Cannara Biotech Inc., together with its subsidiaries, engages in the indoor cultivation, processing, and sale of cannabis and cannabis-derivated products in Canada. It also offers hemp-based CBD products through e-commerce platform. The company was incorporated in 2017 and is headquartered in Saint-Laurent, Canada.
Saint-Laurent, QC H4N 3M9
:
ISIN: CA13765U2002
:
